Sort   by:  
 Page size 
Abstract Introduction: CHEK2 is a moderate penetrance breast cancer risk gene, whose truncating mutation 1100delC increases the risk about two fold. We pursued to investigate gene copy number aberrations and gene expression profiles that are typical for breast tumors of CHEK2 1100delC mutation carri...
ORGANISM(S): Homo sapiens 
Introduction: CHEK2 is a moderate penetrance breast cancer risk gene, whose truncating mutation 1100delC increases the risk about two fold. We pursued to investigate gene copy number aberrations and gene expression profiles that are typical for breast tumors of CHEK2 1100delC mutation carriers. Mat...
ORGANISM(S): Homo sapiens 
183 breast tumors from the Helsinki Univerisity Central Hospital with survival information 183 breast tumors from the Helsinki Univerisity Central Hospital with survival information
ORGANISM(S): Homo sapiens 
Comparison of the tumors PTEN promoter variant carrier and non carrier gene expression profiles. Expression profiles of 10 breast cancer patients with PTEN promoter variant and 10 controls matches for histology, ER, PR, T, N, M, Grade, HER2, Ki67, and p53.
ORGANISM(S): Homo sapiens 
Breast cancer is a profoundly heterogeneous disease with respect to biological and clinical behavior. Gene expression profiling has been used to dissect this complexity and stratify tumors into intrinsic gene expression subtypes associated with distinct biology, patient outcome and different genomic...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size